Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men

Circulation

Volumn 105, Issue 22, 2002, Pages 2632-2637

  Engstrom G ^a   Lind, P ^a   Hedblad, B ^a   Stavenow, L ^a   Janzon, L ^a   Lindgarde F ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cholesterol; Epidemiology; Inflammation; Myocardial infarction; Stroke

Indexed keywords

ALPHA 1 ANTITRYPSIN; CERULOPLASMIN; CHOLESTEROL; FIBRINOGEN; HAPTOGLOBIN; OROSOMUCOID;

ADULT; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; STROKE;

ADULT; ALPHA 1-ANTITRYPSIN; BIOLOGICAL MARKERS; BLOOD PROTEINS; CEREBROVASCULAR ACCIDENT; CERULOPLASMIN; CHOLESTEROL; COHORT STUDIES; COMORBIDITY; FIBRINOGEN; FOLLOW-UP STUDIES; HAPTOGLOBINS; HUMANS; HYPERCHOLESTEROLEMIA; INCIDENCE; INFLAMMATION; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; OROSOMUCOID; RISK FACTORS; SWEDEN;

EID: 0037024226     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000017327.69909.FF     Document Type: Article

References (33)

1. Plasma lipids and stroke
2. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial
3. Management of risk factors
4. Is cholesterol a risk factor for stroke? Yes
5. Is cholesterol a risk factor for stroke? No
6. Natural statins and stroke risk
7. Reduction of stroke events with pravastatin: The Prospective Pravastatin Pooling (PPP) Project
8. Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: A long-term cohort study
9. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
10. Fibrinogen and cardiovascular risk
11. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
12. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
13. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
14. Joint effects of C-reactive protein and other risk factors on acute coronary events
15. C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons
16. Fibrinogen as a risk factor for stroke and myocardial infarction
17. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
18. Long-term outcome of the Malmö preventive project: Mortality and cardiovascular morbidity
19. Electroimmunoassay
20. Distribution and determinants of ischaemic heart disease in an urban population: A study from the myocardial infarction register in Malmö, Sweden
21. Geographical distribution of stroke in an urban population: Relationships with prevalence of risk factors and socioeconomic circumstances
22. Atherosclerosis: An inflammatory disease
23. Does inflammation contribute to thrombotic events?
24. Inflammation and thrombosis: The clot thickens
25. Current concepts of the pathogenesis of the acute coronary syndromes
26. Acute-phase proteins and other systemic responses to inflammation
27. Lipoprotein trafficking in vascular cells: Molecular Trojan horses and cellular saboteurs
28. Serum total cholesterol and mortality: Confounding factors and risk modification in Japanese-American men
29. The relation between cholesterol and haemorrhagic or ischaemic stroke in the Renfrew/Paisley study
30. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: The Copenhagen City Heart Study
31. Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study
32. High-density lipoprotein cholesterol and ischemic stroke in the elderly: The Northern Manhattan Stroke Study